Business
MedQuist revamps billing practices
NEWS IN BRIEF — Posted Jan. 31, 2005
MedQuist announced Jan. 10 that it was ending certain billing practices that caused it to overcharge hospitals and physician groups for medical transcription services. The Mt. Laurel, N.J., company said it no longer would use certain ratios and formulas instead of actual line counts to determine billing.
MedQuist is under investigation by the Securities and Exchange Commission and faces lawsuits from shareholders and customers. The company, which was delisted from NASDAQ in June 2004, trades on the Pink Sheets, a private exchange in New York.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2005/01/31/bibf0131.htm.












